Multivariable Analyses of Prognostic Factors for Progression-Free Survival (PFS) and Complete Response (CR) with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the Determination Phase 3 Trial

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2022-11, Vol.140 (Supplement 1), p.4834-4838
Hauptverfasser:	Hassoun, Hani, Jacobus, Susanna J., Richardson, Paul G., Zonder, Jeffrey A., Voorhees, Peter M., Kaufman, Jonathan L., Yee, Andrew J., Scott, Emma C., Torka, Pallawi, Libby, Edward, Reeves, Brandi, Wang, Michael L., Anderson, Larry D., Milner, Carter, Gasparetto, Cristina J., Agha, Mounzer, Khan, Abdullah, Hurd, David Duane, Avigan, David, Costello, Caitlin, Jakubowiak, Andrzej, Lonial, Sagar, Raje, Noopur, Medvedova, Eva, McCarthy, Philip L., Orlowski, Robert Z., Nadeem, Omar, Laubach, Jacob P., Pasquini, Marcelo C., Giralt, Sergio A., Masone, Kelly, Samur, Mehmet K., Perrot, Aurore, Moreau, Philippe, Avet-Loiseau, Herve, Weller, Edie A., Munshi, Nikhil C., Anderson, Kenneth C.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!